List of Tables
Table 1. Human Microbiome Therapeutic Drugs Market Trends
Table 2. Human Microbiome Therapeutic Drugs Market Drivers & Opportunity
Table 3. Human Microbiome Therapeutic Drugs Market Challenges
Table 4. Human Microbiome Therapeutic Drugs Market Restraints
Table 5. Global Human Microbiome Therapeutic Drugs Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Human Microbiome Therapeutic Drugs Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Human Microbiome Therapeutic Drugs Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Human Microbiome Therapeutic Drugs Product Type
Table 9. Key Companies Time to Begin Mass Production of Human Microbiome Therapeutic Drugs
Table 10. Global Human Microbiome Therapeutic Drugs Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome Therapeutic Drugs as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Human Microbiome Therapeutic Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Human Microbiome Therapeutic Drugs Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Human Microbiome Therapeutic Drugs Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Human Microbiome Therapeutic Drugs Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Human Microbiome Therapeutic Drugs Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Human Microbiome Therapeutic Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Human Microbiome Therapeutic Drugs Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Human Microbiome Therapeutic Drugs Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Human Microbiome Therapeutic Drugs Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Human Microbiome Therapeutic Drugs Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Human Microbiome Therapeutic Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Human Microbiome Therapeutic Drugs Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Human Microbiome Therapeutic Drugs Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Human Microbiome Therapeutic Drugs Sales Value by Region (2019-2024) & (%)
Table 27. Global Human Microbiome Therapeutic Drugs Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Human Microbiome Therapeutic Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Human Microbiome Therapeutic Drugs Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Human Microbiome Therapeutic Drugs Sales Value, (2025-2030) & (US$ Million)
Table 31. Rebiotix Basic Information List
Table 32. Rebiotix Description and Business Overview
Table 33. Rebiotix Human Microbiome Therapeutic Drugs Products, Services and Solutions
Table 34. Revenue (US$ Million) in Human Microbiome Therapeutic Drugs Business of Rebiotix (2019-2024)
Table 35. Rebiotix Recent Developments
Table 36. Seres Therapeutics Basic Information List
Table 37. Seres Therapeutics Description and Business Overview
Table 38. Seres Therapeutics Human Microbiome Therapeutic Drugs Products, Services and Solutions
Table 39. Revenue (US$ Million) in Human Microbiome Therapeutic Drugs Business of Seres Therapeutics (2019-2024)
Table 40. Seres Therapeutics Recent Developments
Table 41. Vedanta Biosciences Basic Information List
Table 42. Vedanta Biosciences Description and Business Overview
Table 43. Vedanta Biosciences Human Microbiome Therapeutic Drugs Products, Services and Solutions
Table 44. Revenue (US$ Million) in Human Microbiome Therapeutic Drugs Business of Vedanta Biosciences (2019-2024)
Table 45. Vedanta Biosciences Recent Developments
Table 46. Bristol-Myers Squibb Basic Information List
Table 47. Bristol-Myers Squibb Description and Business Overview
Table 48. Bristol-Myers Squibb Human Microbiome Therapeutic Drugs Products, Services and Solutions
Table 49. Revenue (US$ Million) in Human Microbiome Therapeutic Drugs Business of Bristol-Myers Squibb (2019-2024)
Table 50. Bristol-Myers Squibb Recent Developments
Table 51. Johnson and Johnson Basic Information List
Table 52. Johnson and Johnson Description and Business Overview
Table 53. Johnson and Johnson Human Microbiome Therapeutic Drugs Products, Services and Solutions
Table 54. Revenue (US$ Million) in Human Microbiome Therapeutic Drugs Business of Johnson and Johnson (2019-2024)
Table 55. Johnson and Johnson Recent Developments
Table 56. Takeda Basic Information List
Table 57. Takeda Description and Business Overview
Table 58. Takeda Human Microbiome Therapeutic Drugs Products, Services and Solutions
Table 59. Revenue (US$ Million) in Human Microbiome Therapeutic Drugs Business of Takeda (2019-2024)
Table 60. Takeda Recent Developments
Table 61. ENTEROME Bioscience Basic Information List
Table 62. ENTEROME Bioscience Description and Business Overview
Table 63. ENTEROME Bioscience Human Microbiome Therapeutic Drugs Products, Services and Solutions
Table 64. Revenue (US$ Million) in Human Microbiome Therapeutic Drugs Business of ENTEROME Bioscience (2019-2024)
Table 65. ENTEROME Bioscience Recent Developments
Table 66. Key Raw Materials Lists
Table 67. Raw Materials Key Suppliers Lists
Table 68. Human Microbiome Therapeutic Drugs Downstream Customers
Table 69. Human Microbiome Therapeutic Drugs Distributors List
Table 70. Research Programs/Design for This Report
Table 71. Key Data Information from Secondary Sources
Table 72. Key Data Information from Primary Sources
Table 73. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Human Microbiome Therapeutic Drugs Product Picture
Figure 2. Global Human Microbiome Therapeutic Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Human Microbiome Therapeutic Drugs Sales Value (2019-2030) & (US$ Million)
Figure 4. Human Microbiome Therapeutic Drugs Report Years Considered
Figure 5. Global Human Microbiome Therapeutic Drugs Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Microbiome Therapeutic Drugs Revenue in 2023
Figure 7. Human Microbiome Therapeutic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. FMT Picture
Figure 9. Microbiome Drugs Picture
Figure 10. Others Picture
Figure 11. Global Human Microbiome Therapeutic Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Human Microbiome Therapeutic Drugs Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Stomach
Figure 14. Product Picture of Oral
Figure 15. Product Picture of Respiratory Tract
Figure 16. Product Picture of Others
Figure 17. Global Human Microbiome Therapeutic Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Human Microbiome Therapeutic Drugs Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America Human Microbiome Therapeutic Drugs Sales Value (2019-2030) & (US$ Million)
Figure 20. North America Human Microbiome Therapeutic Drugs Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe Human Microbiome Therapeutic Drugs Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe Human Microbiome Therapeutic Drugs Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific Human Microbiome Therapeutic Drugs Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific Human Microbiome Therapeutic Drugs Sales Value by Country (%), 2023 VS 2030
Figure 25. South America Human Microbiome Therapeutic Drugs Sales Value (2019-2030) & (US$ Million)
Figure 26. South America Human Microbiome Therapeutic Drugs Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa Human Microbiome Therapeutic Drugs Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa Human Microbiome Therapeutic Drugs Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions Human Microbiome Therapeutic Drugs Sales Value (%), (2019-2030)
Figure 30. United States Human Microbiome Therapeutic Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States Human Microbiome Therapeutic Drugs Sales Value by Type (%), 2023 VS 2030
Figure 32. United States Human Microbiome Therapeutic Drugs Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe Human Microbiome Therapeutic Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe Human Microbiome Therapeutic Drugs Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe Human Microbiome Therapeutic Drugs Sales Value by Application (%), 2023 VS 2030
Figure 36. China Human Microbiome Therapeutic Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 37. China Human Microbiome Therapeutic Drugs Sales Value by Type (%), 2023 VS 2030
Figure 38. China Human Microbiome Therapeutic Drugs Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan Human Microbiome Therapeutic Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan Human Microbiome Therapeutic Drugs Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan Human Microbiome Therapeutic Drugs Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea Human Microbiome Therapeutic Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea Human Microbiome Therapeutic Drugs Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea Human Microbiome Therapeutic Drugs Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia Human Microbiome Therapeutic Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Human Microbiome Therapeutic Drugs Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia Human Microbiome Therapeutic Drugs Sales Value by Application (%), 2023 VS 2030
Figure 48. India Human Microbiome Therapeutic Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 49. India Human Microbiome Therapeutic Drugs Sales Value by Type (%), 2023 VS 2030
Figure 50. India Human Microbiome Therapeutic Drugs Sales Value by Application (%), 2023 VS 2030
Figure 51. Human Microbiome Therapeutic Drugs Industrial Chain
Figure 52. Human Microbiome Therapeutic Drugs Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
